NASDAQ: AMST · Technology · 5 alerts · CIK 1807166
Share price
$0.5468Close, Nov 16
Market cap
$3.58M
Shares outstanding
6.55MLatest SEC cover page
Sector
Technology
Industry
Services-Prepackaged SoftwareSIC 7372
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Amesite Inc. filings on SEC EDGAR ↗
Amesite Inc. entered into a new NurseMagic enterprise agreement with a healthcare organization serving approximately 2,000 patients. The contract involves deploying Amesite's AI-native documentation platform to automate EMR assessments and care plans. While the specific counterparty name and deal value were not disclosed, the company framed the win as a material expansion of its recurring revenue and enterprise user base.
Amesite Inc. reported a net loss of $774,395 for the quarter ended September 30, 2026, compared to a loss of $642,266 in the prior year period, driven by increased technology and content development costs. The company's management expressed substantial doubt about its ability to continue as a going concern, noting that current cash reserves may not sustain operations for the next twelve months.
Amesite Inc. received a deficiency notice from Nasdaq on November 11, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Management is monitoring the situation and may consider a reverse stock split if necessary to maintain its listing on The Nasdaq Capital Market.
Amesite Inc. has scheduled its next Annual Meeting of Stockholders for December 10, 2026. The company established September 27, 2026, as the deadline for stockholders to submit proposals or director nominations for inclusion in the proxy materials.
Amesite Inc. has prepared presentation materials for use at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026. The presentation highlights the company's AI-powered enterprise solutions for the $1.5 trillion post-acute care market, including its NurseMagic B2B platform and EMR functionality. The company reported international reach across 21 countries and high user ratings for its clinical documentation applications.
Counterparty
H.C. Wainwright 28th Annual Global Investment Conference